RESUMEN
BACKGROUND: Drug-related problems (DRPs) are common among patients seen in the emergency department (ED), but the true incidence is not clear. OBJECTIVES: The primary objective of this study was to determine the prevalence of DRPs among patients seen in a U.S. ED. The secondary objective was to categorize these DRPs by problem type and by medication class. METHODS: This was a prospective observational cohort study of a random sample of ED patients between December 2011 and March 2013. ED pharmacists screened randomly selected patients for the presence of a DRP contributing to the ED visit. Four independent auditors evaluated the results to achieve consensus for the presence or absence of DRPs and categorization of the DRPs. RESULTS: Among 1039 patients screened for DRPs, 308 (29.6%) were found to have at least 1 DRP contributing to the ED visit. Among a total of 443 DRPs, the most commonly identified categories were adverse drug reaction (n = 193 [43.6%]), ineffective medication (n = 69 [15.6%]), and subtherapeutic dosage (n = 68 [15.3%]). The most commonly implicated drug classes were cardiovascular medications (n = 113 [26.5%]), anti-infective medications (n = 52 [12.2%]), and analgesic medications (n = 58 [13.6%]). CONCLUSIONS: A substantial proportion of ED visits are associated in part or in total with DRPs. Adverse drug reactions and cardiovascular medications are the most common category and medication class implicated, respectively.
Asunto(s)
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Farmacéuticos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Servicio de Urgencia en Hospital , Humanos , Prevalencia , Estudios ProspectivosAsunto(s)
Suplementos Dietéticos/estadística & datos numéricos , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/terapia , Suplementos Dietéticos/efectos adversos , Femenino , Tasa de Filtración Glomerular/fisiología , Humanos , Incidencia , Masculino , Encuestas Nutricionales , Pronóstico , Estudios Retrospectivos , Medición de Riesgo , Sensibilidad y Especificidad , Índice de Severidad de la EnfermedadRESUMEN
Glucagon is critically underutilized, and we explored whether this is due to inadequate glucagon prescribing or the patient's inability to fill prescriptions. Of 216 commercially insured, high-risk individuals with diabetes who were prescribed glucagon in our healthcare system, 142 (65.4%) had a claim indicating its fill within 30 days.
Asunto(s)
Diabetes Mellitus , Glucagón , Humanos , Estados Unidos , Glucagón/uso terapéutico , Estudios Retrospectivos , Diabetes Mellitus/tratamiento farmacológico , PrescripcionesRESUMEN
AIMS: To examine glucagon prescribing trends among patients at high risk of severe hypoglycemia and assess if a glucagon prescription is associated with lower rates of severe hypoglycemia requiring hospital care. METHODS: Retrospective analysis of electronic health records from a large integrated healthcare system between May 2019 and August 2021. We included adults (≥18 years) with type 1 diabetes or with type 2 diabetes treated with short-acting insulin and/or recent history of hypoglycemia-related emergency department visit or hospitalization. We calculated rates of glucagon prescribing overall and by patient characteristics. We then matched 1:1 those who were and were not prescribed glucagon and assessed subsequent hypoglycemia-related hospitalization. RESULTS: Of 9,200 high risk adults, 2063 (22.4%) were prescribed glucagon. Among patients more likely to be prescribed glucagon were those younger, female, White, living in urban areas, with prior severe hypoglycemia, and with a recent endocrinology specialist visit. In the matched cohort (N = 1707 per arm), 62 prescribed glucagon and 33 not prescribed glucagon were hospitalized for hypoglycemia (adjusted incidence rate ratio 1.71, 95% CI 1.10-2.66; P = 0.018). CONCLUSION: Glucagon prescribing was infrequent with significant racial and rural disparities. Patients with glucagon prescriptions did not have lower rates of hospitalization for hypoglycemia.
Asunto(s)
Diabetes Mellitus Tipo 2 , Hipoglucemia , Adulto , Humanos , Femenino , Glucagón/uso terapéutico , Diabetes Mellitus Tipo 2/complicaciones , Hipoglucemiantes/uso terapéutico , Estudios Retrospectivos , Hipoglucemia/tratamiento farmacológico , Hipoglucemia/epidemiología , Hipoglucemia/prevención & control , HospitalizaciónRESUMEN
PURPOSE: As the prevalence of provider burnout continues to increase, it is critical to identify interventions that may impact provider satisfaction, such as an integrated clinical pharmacist. This study aimed to assess the perceived effect of pharmacist integration on primary care provider satisfaction and drivers of provider burnout in the primary care setting. METHODS: A cross-sectional survey with 11 questions across 4 domains was distributed to primary care providers in a large integrated health system. RESULTS: Of 295 providers invited to take the survey, 119 responded (40% response rate). Most providers had worked with a pharmacist for at least 2 years and utilized them weekly or daily. At least 87% of provider respondents strongly agreed or somewhat agreed that the integrated clinical pharmacist reduced their workload by working directly with patients and non-provider staff, improved overall medication use, helped patients meet health goals and quality measures, and overall helped them to effectively manage their panel of patients. Providers found greater meaning in work through the presence of the clinical pharmacist, which allowed them more time to focus on professionally fulfilling aspects of their work and helped them feel less emotional exhaustion. Overall, 91% of providers were extremely satisfied with the clinical pharmacy service. CONCLUSIONS: These findings may be used to justify the expansion of clinical pharmacy services in primary care to practice areas experiencing problems with 4 specific drivers of provider burnout: workload and job demands, efficiency and resources, meaning in work, and social support and community at work.
Asunto(s)
Agotamiento Profesional , Farmacéuticos , Agotamiento Profesional/prevención & control , Estudios Transversales , Humanos , Satisfacción en el Trabajo , Atención Primaria de Salud , Encuestas y CuestionariosRESUMEN
OBJECTIVE: To compare the availability of medication therapy management (MTM) services, point-of-care (POC) testing, and disease management resources between rural and urban Minnesota community pharmacies. DESIGN: Cross-sectional study. SETTING: Minnesota in 2006. PARTICIPANTS: Owners and operational managers of 564 Minnesota community pharmacies. INTERVENTION: Mail survey containing structured, quantitative questions. Resulting data were separated to evaluate urban and rural area community pharmacies. MAIN OUTCOME MEASURES: Staffing trends, MTM services, and patient care services of urban compared with rural community pharmacies in Minnesota. RESULTS: Urban and rural pharmacies reported allocating nearly the same percent of a typical day to filling and dispensing prescriptions (approximately 70%). A higher percent of rural community pharmacies offered patient care services in 5 of 15 categories, including drug information services (55.7% vs. 45.6%), provision of durable medical equipment (43.4% vs. 32.6%), dyslipidemia management (7.8% vs. 3.8%), hypertension management (14.6%% vs. 7.3%), and MTM (29.4% vs. 18.7%). CONCLUSION: Although the time allocated to dispensing medication was approximately 70% for both urban and rural pharmacies, a significantly higher proportion of rural pharmacies reported providing MTM and other direct patient care services. This may be a result of geographic isolation and greater use of pharmacists as providers of first-contact care in these areas.
Asunto(s)
Manejo de Atención al Paciente/métodos , Farmacias/estadística & datos numéricos , Población Rural , Población Urbana , Estudios Transversales , Manejo de la Enfermedad , Encuestas de Atención de la Salud , Humanos , Administración del Tratamiento Farmacológico , Minnesota , Admisión y Programación de Personal/estadística & datos numéricos , Sistemas de Atención de PuntoRESUMEN
In this article, we describe the implementation of a team-based care model during the first 2 years (2016-2017) after Mayo Clinic designed and built a new primary care clinic in Rochester, Minnesota. The clinic was configured to accommodate a team-based care model that included complete colocation of clinical staff to foster collaboration, designation of a physician team manager to support a physician to advanced practice practitioner ratio of 1:2, expanded roles for registered nurses, and integration of clinical pharmacists, behavioral health specialists, and community specialists; this model was designed to accommodate the growth of nonvisit care. We describe the implementation of this team-based care model and the key metrics that were tracked to assess performance related to the quadruple aim of improving population health, improving patient experience, reducing cost, and supporting care team's work life.
Asunto(s)
Implementación de Plan de Salud , Grupo de Atención al Paciente/estadística & datos numéricos , Atención Primaria de Salud , Prestación Integrada de Atención de Salud , Grupos Focales , Humanos , Minnesota , Enfermeras y Enfermeros , Grupo de Atención al Paciente/organización & administración , Atención Dirigida al Paciente , Farmacéuticos , MédicosRESUMEN
To reliably assess quality, a standardized electronic approach is needed to identify bleeding events. The study aims were the following: (1) clinically validate an electronic health record-based algorithm for bleeding and (2) assess interrater results to determine validity and reliability. Data were analyzed before and after implementation of a pharmacist-managed warfarin protocol. Bleeding was based on ≥2 of 3 criteria: (1) diagnosis indicating bleeding, (2) lab value decrease suggesting bleeding, and (3) blood product use. All suspected bleeds (234) and a sample (58) not meeting criteria were compared with clinical review. There were 234 bleeding cases identified electronically. Reviewer agreement was 78.2% (κ = 0.565). Algorithm sensitivity was 93.9% and positive predictive value 46.2%. Algorithm identification was least accurate for those with only 2 criteria but good for those with all criteria. This study supports using multiple electronic criteria to identify bleeding events. However, cases having exactly 2 criteria may require manual review for validation.
Asunto(s)
Anticoagulantes/efectos adversos , Registros Electrónicos de Salud/organización & administración , Hemorragia/inducido químicamente , Mejoramiento de la Calidad/organización & administración , Warfarina/efectos adversos , Algoritmos , Protocolos Clínicos , Femenino , Hemorragia/prevención & control , Humanos , Masculino , Seguridad del Paciente , Reproducibilidad de los Resultados , Estudios RetrospectivosRESUMEN
BACKGROUND: The optimization of medication use during care transitions represents an opportunity to improve overall health-related outcomes. The utilization of clinical pharmacists during care transitions has demonstrated benefit, although the optimal method of integration during the care transition process remains unclear. OBJECTIVE: To evaluate the impact of pharmacist-provided telephonic medication therapy management (MTM) on care quality in a care transitions program (CTP) for high-risk older adults. METHODS: This prospective, randomized, controlled study was conducted from December 8, 2011, through October 25, 2012, in a primary care work group at a tertiary care academic medical center in the midwestern United States. High-risk elderly (aged ≥60 years) patients were randomized to a pharmacist-provided MTM program via telephone or to usual care within an existing outpatient CTP. The primary outcome was the quality of medication prescribing and utilization based on the Screening Tool to Alert Doctors to the Right Treatment (START) and the Screening Tool of Older Persons' Prescriptions (STOPP) scores. The secondary outcomes were medication utilization using a modified version of the Medication Appropriateness Index, hospital resource utilization within 30 days of discharge, and drug therapy problems. RESULTS: Of 222 eligible high-risk patients, 25 were included in the study and were randomized to the pharmacist MTM intervention (N = 13) or to usual care (N = 12). No significant differences were found between the 2 groups in medications meeting the STOPP or START criteria. At 30-day follow-up, no significant differences were found between the 2 cohorts in medication utilization quality indicators or in hospital utilization. At 30-day follow-up, 3 (13.6%) patients had an emergency department visit or a hospital readmission since discharge. In all, 22 patients completed the study. Medication underuse was common, with 20 START criteria absent medications evident for all 25 patients at baseline, representing 15 (60%) patients with ≥1 missing medications. Overall, 55 drug therapy problems were identified at baseline, 24 (43.6%) of which remained unresolved at 30-day follow-up. CONCLUSION: The use of a pharmacist-provided MTM program did not achieve a significant difference compared with usual care in an existing CTP; however, the findings demonstrated frequent utilization of inappropriate medications as well as medication underuse, and many drug therapy problems remained unresolved. The small size of the study may have limited the ability to detect a difference between the intervention and usual care groups.